BBLGW
Bone Biologics Corp WarrantsNASDAQ
Updated 5 days ago
Coverage limited
$7.70+17.83%
Close Oct 9, 2026
- Market cap
- —
- 1 month
- —
- 3 months
- —
- 1 year
- —
- Dividend
- No dividends on record
- Short interest
- 150 sharessettled Sep 15, 2026 · -58.6% since Feb 13, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if BBLGW is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
0 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
2 filers reported a long position in BBLGW for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| CITADEL ADVISORS LLC | $396K | 26.4K | -11.3% |
| UBS Group AG | $4.1K | 513 | +21.6% |
Get the Full Analysis for BBLGW
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.